| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |